Bill to recognise pharmacists qualified under J-K Pharmacy Act passed in Lok Sabha

Replying to the short debate on the Bill, Mandaviya said the amendments to the Pharmacy Act will enable the youth to take up even government jobs.;

Published On 2023-08-09 08:00 GMT | Update On 2023-08-09 08:00 GMT

New Delhi: The Lok Sabha on Monday passed a bill allowing persons qualified or registered under the Jammu and Kashmir Pharmacy Act to be registered as pharmacists under the Pharmacy Act, thus doing away with the ambiguity with regard to the two legislations. Piloting the Pharmacy (Amendment) Bill, 2023, Health Minister Mansukh Mandaviya said that changes will increase job opportunities for the youth of Jammu and Kashmir.

The bill, which was passed by voice vote in the Lower House, seeks to do away with issues concerning the status of persons registered or qualified under the Jammu and Kashmir Pharmacy Act.

Under the current dispensation, registration under the Pharmacy Act is mandatory for persons practising pharmacy in the country.

"Any person whose name has been entered in the register of pharmacists maintained under the Jammu and Kashmir Pharmacy Act, 2011, or possesses qualification (medical assistant/ pharmacists)... shall be deemed to have been entered in the register of pharmacists prepared and maintained under Chapter IV of this (Pharmacy) Act," said the statement of objects and reasons of the bill.

Replying to the short debate on the Bill, Mandaviya said the situation in Jammu and Kashmir has changed significantly after the abrogation of Article 370 and the amendments to the Pharmacy Act will enable the youth to take up even government jobs.

He further said the facility of tele-consultation is now available in Jammu and Kashmir and people are taking advantage of it to get the best possible medical treatment.

The minister further said that the government's Production Linked Incentive (PLI) scheme is transforming the healthcare sector in the country with domestic industry taking up production of critical medicine and reducing dependence on imports.

He said that soon 38 out of 52 critical active pharmaceutical ingredients (API) will be produced within the country.

Mandaviya said that Ayushman Bharat Scheme has ensured quality medical treatment even for poor people. Similarly, Jan Aushadhi Kendras are making generic medicines available to people at lower cost.

Read also: India has started manufacturing 38 APIs in past 1.5 years: Union Health Minister

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bill to recognise pharmacists qualified under J-K Pharmacy Act passed in Lok Sabha

Replying to the short debate on the Bill, Mandaviya said the amendments to the Pharmacy Act will enable the youth to take up even government jobs.;

Similar News

Dr Reddys Labs gets 5 observations from USFDA for Bachupally facility

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility

Delhi HC Refuses to Lift Ban on Medipol Pharma After Substandard Clarithromycin, Noscapine Supplied to Armed Forces

Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in Expansion

USFDA Reappoints Vinay Prasad to Top Medical and Scientific Role

B Pharmacy Graduate Held for Operating Unauthorized Clinic in Hyderabad

No Generics for AbbVie's Rinvoq Until 2037, Analysts See Multi-Billion Dollar Boost

Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026